Skip to main content

Advertisement

SpringerLink
Log in

Assessment and treatment of short stature in pediatric patients with chronic kidney disease: a consensus statement

  • Conference Report
  • Published:
Pediatric Nephrology Aims and scope Submit manuscript

Abstract

Growth failure is a clinically important issue in children with chronic kidney disease (CKD) and is associated with significant morbidity and mortality. Many factors contribute to impaired growth in these children, including abnormalities in the growth hormone (GH)–insulin-like growth factor-I (IGF-I) axis, malnutrition, acidosis, and renal bone disease. The management of growth failure in children with CKD is complicated by the presence of other disease-related complications requiring medical intervention. Despite evidence of GH efficacy and safety in this population, some practitioners and families have been reluctant to institute GH therapy, citing an unwillingness to comply with daily injections, reimbursement difficulties, or impending renal transplantation. Suboptimal attention to growth failure management may be further compounded by a lack of clinical guidelines for the appropriate assessment and treatment of growth failure in these children. This review of growth failure in children with CKD concludes with an algorithm developed by members of the consensus committee, outlining their recommendations for appropriate steps to improve growth and overall health outcomes in children with CKD.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

References

  1. Furth SL, Stablein D, Fine RN, Powe NR, Fivush BA (2002) Adverse clinical outcomes associated with short stature at dialysis initiation: a report of the North American Pediatric Renal Transplant Cooperative Study. Pediatrics 109:909–913

    Article  PubMed  Google Scholar 

  2. Furth SL, Hwang W, Yang C, Neu AM, Fivush BA, Powe NR (2002) Growth failure, risk of hospitalization and death for children with end-stage renal disease. Pediatr Nephrol 17:450–455

    Article  PubMed  Google Scholar 

  3. Hokken-Koelega AC, Saenger P, Cappa M, Greggio N (2001) Unresolved problems concerning optimal therapy of puberty in children with chronic renal diseases. J Pediatr Endocrinol Metab 14 [Suppl 2]:945–952

    PubMed  Google Scholar 

  4. Kari JA, Gonzalez C, Ledermann SE, Shaw V, Rees L (2000) Outcome and growth of infants with severe chronic renal failure. Kidney Int 57:1681–1687

    Article  CAS  PubMed  Google Scholar 

  5. Kuizon BD, Salusky IB (1999) Growth retardation in children with chronic renal failure. J Bone Miner Res 14:1680–1690

    Article  CAS  PubMed  Google Scholar 

  6. Postlethwaite RJ, Eminson DM, Reynolds JM, Wood AJ, Hollis S (1998) Growth in renal failure: a longitudinal study of emotional and behavioural changes during trials of growth hormone treatment. Arch Dis Child 78:222–229

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Scharer K (1990) Growth and development of children with chronic renal failure. Study Group on Pubertal Development in Chronic Renal Failure. Acta Paediatr Scand Suppl 366:90–92

    Article  CAS  PubMed  Google Scholar 

  8. Tonshoff B, Mehls O (1995) Growth retardation in children with chronic renal insufficiency: current aspects of pathophysiology and treatment. J Nephrol 8:133–142

    Google Scholar 

  9. National Kidney Foundation Kidney Disease Outcomes Quality Initiative (2002) K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Part 4. Definition and classification of stages of chronic kidney disease. National Kidney Foundation. Accessed 13 Sept 2004

  10. North American Pediatric Renal Transplant Cooperative Study (2005) Annual Report. Renal transplantation, dialysis, chronic renal insufficiency. Available at: https://doi.org/spitfire.emmes.com/study/ped/resources/annlrept2005.pdf. Accessed 2 Sept 2005

  11. Tonshoff B, Fine RN (1996) Recombinant human growth hormone for children with renal failure. Adv Ren Replace Ther 3:37–47

    Article  CAS  PubMed  Google Scholar 

  12. Stabler B, Siegel PT, Tancer ME (1993) Psychiatric symptoms in young adults treated for growth hormone deficiency in childhood. In: Stabler B, Underwood L (eds) Growth, stature, and adaptation. Behavioral, social and cognitive aspects of growth delay. University of North Carolina, Chapel Hill, NC, pp 99–106

    Google Scholar 

  13. Stabler B, Siegel PT, Clopper RR, Stoppani CE, Compton PG, Underwood LE (1998) Behavior change after growth hormone treatment of children with short stature. J Pediatr 133:366–373

    Article  CAS  PubMed  Google Scholar 

  14. Stabler B, Clopper RR, Siegel PT, Stoppani C, Compton PG, Underwood LE (1994) Academic achievement and psychological adjustment in short children. The National Cooperative Growth Study. J Dev Behav Pediatr 15:1–6

    Article  CAS  PubMed  Google Scholar 

  15. Hokken-Koelega AC, van Zaal MA, van Bergen W, de Ridder MA, Stijnen T, Wolff ED, de Jong RC, Donckerwolcke RA, de Muinck Keizer-Schrama SM, Drop SL (1994) Final height and its predictive factors after renal transplantation in childhood. Pediatr Res 36:323–328

    Article  CAS  PubMed  Google Scholar 

  16. Fine RN, Stablein D (2005) Long-term use of recombinant human growth hormone in pediatric allograft recipients: a report of the NAPRTCS Transplant Registry. Pediatr Nephrol 20:404–408

    Article  PubMed  Google Scholar 

  17. Nissel R, Brazda I, Feneberg R, Wigger M, Greiner C, Querfeld U, Haffner D (2004) Effect of renal transplantation in childhood on longitudinal growth and adult height. Kidney Int 66:792–800

    Article  PubMed  Google Scholar 

  18. Voss LD, Sandberg DE (2004) The psychological burden of short stature: evidence against. Eur J Endocrinol 151 [Suppl 1]:S29–S33

    Article  CAS  PubMed  Google Scholar 

  19. Busschbach JJ, Rikken B, Grobbee DE, De Charro FT, Wit JM (1998) Quality of life in short adults. Horm Res 49:32–38

    Article  CAS  PubMed  Google Scholar 

  20. Broyer M, Le BC, Charbit M, Guest G, Tete MJ, Gangnadoux MF, Niaudet P (2004) Long-term social outcome of children after kidney transplantation. Transplantation 77:1033–1037

    Article  PubMed  Google Scholar 

  21. Rosenkranz J, Reichwald-Klugger E, Oh J, Turzer M, Mehls O, Schaefer F (2005) Psychosocial rehabilitation and satisfaction with life in adults with childhood-onset of end-stage renal disease. Pediatr Nephrol 20:1288–1294

    Article  PubMed  Google Scholar 

  22. Roelfsema V, Clark RG (2001) The growth hormone and insulin-like growth factor axis: its manipulation for the benefit of growth disorders in renal failure. J Am Soc Nephrol 12:1297–1306

    CAS  PubMed  Google Scholar 

  23. Rabkin R, Sun DF, Chen Y, Tan J, Schaefer F (2005) Growth hormone resistance in uremia, a role for impaired JAK/STAT signaling. Pediatr Nephrol 20:313–318

    Article  PubMed  Google Scholar 

  24. Tonshoff B, Kiepe D, Ciarmatori S (2005) Growth hormone/insulin-like growth factor system in children with chronic renal failure. Pediatr Nephrol 20:279–289

    Article  PubMed  Google Scholar 

  25. Schaefer F, Veldhuis JD, Robertson WR, Dunger D, Scharer K (1994) Immunoreactive and bioactive luteinizing hormone in pubertal patients with chronic renal failure. Cooperative Study Group on Pubertal Development in Chronic Renal Failure. Kidney Int 45:1465–1476

    Article  CAS  PubMed  Google Scholar 

  26. Wuhl E, Schaefer F (1999) Puberty in chronic renal failure. Adv Ren Replace Ther 6:335–343

    Article  CAS  PubMed  Google Scholar 

  27. Kaskel F (2003) Chronic renal disease: a growing problem. Kidney Int 64:1141–1151

    Article  PubMed  Google Scholar 

  28. North American Pediatric Renal Transplant Cooperative Study (2003) Annual report. Renal transplantation, dialysis, chronic renal insufficiency. https://doi.org/spitfire.emmes.com/study/ped/resources/annlrept2003.pdf. Accessed 15 Jan 2004

  29. Betts PR, Magrath G (1974) Growth pattern and dietary intake of children with chronic renal insufficiency. Br Med J 2:189–193

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  30. Karlberg J, Schaefer F, Hennicke M, Wingen AM, Rigden S, Mehls O (1996) Early age-dependent growth impairment in chronic renal failure. European Study Group for Nutritional Treatment of Chronic Renal Failure in Childhood. Pediatr Nephrol 10:283–287

    Article  CAS  PubMed  Google Scholar 

  31. Uauy RD, Hogg RJ, Brewer ED, Reisch JS, Cunningham C, Holliday MA (1994) Dietary protein and growth in infants with chronic renal insufficiency: a report from the Southwest Pediatric Nephrology Study Group and the University of California, San Francisco. Pediatr Nephrol 8:45–50

    Article  CAS  PubMed  Google Scholar 

  32. Parekh RS, Flynn JT, Smoyer WE, Milne JL, Kershaw DB, Bunchman TE, Sedman AB (2001) Improved growth in young children with severe chronic renal insufficiency who use specified nutritional therapy. J Am Soc Nephrol 12:2418–2426

    CAS  PubMed  Google Scholar 

  33. Wingen AM, Mehls O (2002) Nutrition in children with preterminal chronic renal failure. Myth or important therapeutic aid? Pediatr Nephrol 17:111–120

    Article  PubMed  Google Scholar 

  34. Caldas A, Broyer M, Dechaux M, Kleinknecht C (1992) Primary distal tubular acidosis in childhood: clinical study and long-term follow-up of 28 patients. J Pediatr 121:233–241

    Article  CAS  PubMed  Google Scholar 

  35. Maniar S, Kleinknecht C, Zhou X, Motel V, Yvert JP, Dechaux M (1996) Growth hormone action is blunted by acidosis in experimental uremia or acid load. Clin Nephrol 46:72–76

    CAS  PubMed  Google Scholar 

  36. Bushinsky DA, Frick KK (2000) The effects of acid on bone. Curr Opin Nephrol Hypertens 9:369–379

    Article  CAS  PubMed  Google Scholar 

  37. Lim VS, Kopple JD (2000) Protein metabolism in patients with chronic renal failure: role of uremia and dialysis. Kidney Int 58:1–10

    Article  CAS  PubMed  Google Scholar 

  38. Boirie Y, Broyer M, Gagnadoux MF, Niaudet P, Bresson JL (2000) Alterations of protein metabolism by metabolic acidosis in children with chronic renal failure. Kidney Int 58:236–241

    Article  CAS  PubMed  Google Scholar 

  39. Kuizon BD, Goodman WG, Juppner H, Boechat I, Nelson P, Gales B, Salusky IB (1998) Diminished linear growth during intermittent calcitriol therapy in children undergoing CCPD. Kidney Int 53:205–211

    Article  CAS  PubMed  Google Scholar 

  40. Hochberg Z (2002) Mechanisms of steroid impairment of growth. Horm Res 58 [Suppl 1]:33–38

    CAS  PubMed  Google Scholar 

  41. National Kidney Foundation Kidney Disease Outcomes Quality Initiative (2000) Clinical practice guidelines for nutrition in chronic renal failure. National Kidney Foundation. Accessed 15 Jan 2004

  42. Kaufman DB (1998) Growth hormone and renal osteodystrophy: a case report. Pediatr Nephrol 12:157–159

    Article  CAS  PubMed  Google Scholar 

  43. Fine RN, Kohaut EC, Brown D, Perlman AJ (1994) Growth after recombinant human growth hormone treatment in children with chronic renal failure: report of a multicenter randomized double-blind placebo-controlled study. Genentech Cooperative Study Group. J Pediatr 124:374–382

    Article  CAS  PubMed  Google Scholar 

  44. Hokken-Koelega A, Mulder P, De Jong R, Lilien M, Donckerwolcke R, Groothof J (2000) Long-term effects of growth hormone treatment on growth and puberty in patients with chronic renal insufficiency. Pediatr Nephrol 14:701–706

    Article  CAS  PubMed  Google Scholar 

  45. Kari JA, Rees L (2005) Growth hormone for children with chronic renal failure and on dialysis. Pediatr Nephrol 20:618–621

    Article  PubMed  Google Scholar 

  46. Haffner D, Schaefer F, Nissel R, Wuhl E, Tonshoff B, Mehls O (2000) Effect of growth hormone treatment on the adult height of children with chronic renal failure. German Study Group for Growth Hormone Treatment in Chronic Renal Failure. N Engl J Med 343:923–930

    Article  CAS  PubMed  Google Scholar 

  47. Hokken-Koelega AC, Stijnen T, de Ridder MA, de Muinck Keizer-Schrama SM, Wolff ED, de Jong MC, Donckerwolcke RA, Groothoff JW, Blum WF, Drop SL (1994) Growth hormone treatment in growth-retarded adolescents after renal transplant. Lancet 343:1313–1317

    Article  CAS  PubMed  Google Scholar 

  48. Berard E, Crosnier H, Six-Beneton A, Chevallier T, Cochat P, Broyer M (1998) Recombinant human growth hormone treatment of children on hemodialysis. French Society of Pediatric Nephrology. Pediatr Nephrol 12:304–310

    Article  CAS  PubMed  Google Scholar 

  49. Jabs K, Van DC, Harmon WE (1993) Growth hormone treatment of growth failure among children with renal transplants. Kidney Int Suppl 43:S71–S75

    CAS  PubMed  Google Scholar 

  50. Guest G, Berard E, Crosnier H, Chevallier T, Rappaport R, Broyer M (1998) Effects of growth hormone in short children after renal transplantation. French Society of Pediatric Nephrology. Pediatr Nephrol 12:437–446

    Article  CAS  PubMed  Google Scholar 

  51. Fine RN, Stablein D, Cohen AH, Tejani A, Kohaut E (2002) Recombinant human growth hormone post-renal transplantation in children: a randomized controlled study of the NAPRTCS. Kidney Int 62:688–696

    Article  CAS  PubMed  Google Scholar 

  52. Vimalachandra D, Craig JC, Cowell CT, Knight JF (2001) Growth hormone treatment in children with chronic renal failure: a meta-analysis of randomized controlled trials. J Pediatr 139:560–567

    Article  CAS  PubMed  Google Scholar 

  53. Maxwell H, Rees L (1998) Randomised controlled trial of recombinant human growth hormone in prepubertal and pubertal renal transplant recipients. British Association for Pediatric Nephrology. Arch Dis Child 79:481–487

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  54. Powell DR, Liu F, Baker BK, Hintz RL, Lee PD, Durham SK, Brewer ED, Frane JW, Watkins SL, Hogg RJ (1997) Modulation of growth factors by growth hormone in children with chronic renal failure. The Southwest Pediatric Nephrology Study Group. Kidney Int 51:1970–1979

    Article  CAS  PubMed  Google Scholar 

  55. Wuhl E, Haffner D, Nissel R, Schaefer F, Mehls O (1996) Short dialyzed children respond less to growth hormone than patients prior to dialysis. German Study Group for Growth Hormone Treatment in Chronic Renal Failure. Pediatr Nephrol 10:294–298

    Article  CAS  PubMed  Google Scholar 

  56. Fine RN, Brown DF, Kuntze J, Wooster P, Kohaut EE (1996) Growth after discontinuation of recombinant human growth hormone therapy in children with chronic renal insufficiency. The Genentech Cooperative Study Group. J Pediatr 129:883–891

    Article  CAS  PubMed  Google Scholar 

  57. Fine RN, Yadin O, Moulton L, Nelson PA, Boechat MI, Lippe BM (1994) Five years experience with recombinant human growth hormone treatment of children with chronic renal failure. J Pediatr Endocrinol 7:1–12

    Article  CAS  PubMed  Google Scholar 

  58. Wollmann HA, Schonau E, Blum WF, Meyer F, Kruse K, Ranke MB (1995) Dose-dependent responses in insulin-like growth factors, insulin-like growth factor-binding protein-3 and parameters of bone metabolism to growth hormone therapy in young adults with growth hormone deficiency. Horm Res 43:249–256

    Article  CAS  PubMed  Google Scholar 

  59. Van Dyck M, Gyssels A, Proesmans W, Nijs J, Eeckels R (2001) Growth hormone treatment enhances bone mineralisation in children with chronic renal failure. Eur J Pediatr 160:359–363

    Article  PubMed  Google Scholar 

  60. Hull KL, Harvey S (2003) Growth hormone therapy and quality of life: possibilities, pitfalls and mechanisms. J Endocrinol 179:311–333

    Article  CAS  PubMed  Google Scholar 

  61. Lilien MR, Schroder CH, Levtchenko EN, Koomans HA (2004) Growth hormone therapy influences endothelial function in children with renal failure. Pediatr Nephrol 19:785–789

    Article  PubMed  Google Scholar 

  62. Lanes R, Gunczler P, Lopez E, Esaa S, Villaroel O, Revel-Chion R (2001) Cardiac mass and function, carotid artery intima–media thickness, and lipoprotein levels in growth hormone-deficient adolescents. J Clin Endocrinol Metab 86:1061–1065

    Article  CAS  PubMed  Google Scholar 

  63. Szczepaniska KJ, Tolwinska J, Urban M, Gardziejczyk M, Glowinska B (2004) Cardiac mass and function, carotid artery intima media thickness, homocysteine and lipoprotein levels in children and adolescents with growth hormone deficiency. J Pediatr Endocrinol Metab 17:1405–1413

    Google Scholar 

  64. Salerno M, Esposito V, Spinelli L, Di Somma C, Farina V, Muzzica S, de Horatio LT, Lombardi G, Colao A (2004) Left ventricular mass and function in children with GH deficiency before and during 12 months GH replacement therapy. Clin Endocrinol (Oxf) 60:630–636

    Article  CAS  Google Scholar 

  65. Fine RN, Ho M, Tejani A, Blethen S (2003) Adverse events with rhGH treatment of patients with chronic renal insufficiency and end-stage renal disease. J Pediatr 142:539–545

    Article  CAS  PubMed  Google Scholar 

  66. Mentser M, Breen TJ, Sullivan EK, Fine RN (1997) Growth-hormone treatment of renal transplant recipients: the National Cooperative Growth Study experience—a report of the National Cooperative Growth Study and the North American Pediatric Renal Transplant Cooperative Study. J Pediatr 131:S20–S24

    Article  CAS  PubMed  Google Scholar 

  67. Haffner D, Nissel R, Wuhl E, Schaefer F, Bettendorf M, Tonshoff B, Mehls O (1998) Metabolic effects of long-term growth hormone treatment in prepubertal children with chronic renal failure and after kidney transplantation. Pediatr Res 43:209–215

    Article  CAS  PubMed  Google Scholar 

  68. Saenger P, Attie KM, DiMartino-Nardi J, Fine RN (1996) Carbohydrate metabolism in children receiving growth hormone for 5 years. Chronic renal insufficiency compared with growth hormone deficiency, Turner syndrome, and idiopathic short stature. Genentech Collaborative Group. Pediatr Nephrol 10:261–263

    Article  CAS  PubMed  Google Scholar 

  69. Hertel NT, Holmberg C, Ronnholm KA, Jacobsen BB, Olgaard K, Meeuwisse GW, Rix M, Pedersen FB (2002) Recombinant human growth hormone treatment, using two dose regimens in children with chronic renal failure—a report on linear growth and adverse effects. J Pediatr Endocrinol Metab 15:577–588

    Article  CAS  PubMed  Google Scholar 

  70. Boechat MI, Winters WD, Hogg RJ, Fine RN, Watkins SL (2001) Avascular necrosis of the femoral head in children with chronic renal disease. Radiology 218:411–413

    Article  CAS  PubMed  Google Scholar 

  71. Hokken-Koelega AC, Stijnen T, de Muinck Keizer-Schrama SM, Wit JM, Wolff ED, de Jong MC, Donckerwolcke RA, Abbad NC, Bot A, Blum WF (1991) Placebo-controlled, double-blind, cross-over trial of growth hormone treatment in prepubertal children with chronic renal failure. Lancet 338:585–590

    Article  CAS  PubMed  Google Scholar 

  72. Hokken-Koelega AC, Stijnen T, de Jong MC, Donckerwolcke RA, de Muinck Keizer-Schrama SM, Blum WF, Drop SL (1994) Double blind trial comparing the effects of two doses of growth hormone in prepubertal patients with chronic renal insufficiency. J Clin Endocrinol Metab 79:1185–1190

    CAS  PubMed  Google Scholar 

  73. Hokken-Koelega AC, Stijnen T, de Jong RC, Donckerwolcke RA, Groothoff JW, Wolff ED, Blum WF, de Muinck Keizer-Schrama SM, Drop SL (1996) A placebo-controlled, double-blind trial of growth hormone treatment in prepubertal children after renal transplant. Kidney Int Suppl 53:S128–S134

    CAS  PubMed  Google Scholar 

  74. Genentech (2005) Nutropin AQ [somatropin (rDNA origin) injection]. Prescribing information

  75. Mauras N, Attie KM, Reiter EO, Saenger P, Baptista J (2000) High dose recombinant human growth hormone (GH) treatment of GH-deficient patients in puberty increases near-final height: a randomized, multicenter trial. Genentech Inc Cooperative Study Group. J Clin Endocrinol Metab 85:3653–3660

    CAS  PubMed  Google Scholar 

  76. Mericq MV, Eggers M, Avila A, Cutler GB Jr, Cassorla F (2000) Near final height in pubertal growth hormone (GH)-deficient patients treated with GH alone or in combination with luteinizing hormone-releasing hormone analog: results of a prospective, randomized trial. J Clin Endocrinol Metab 85:569–573

    CAS  PubMed  Google Scholar 

  77. Saggese G, Ranke MB, Saenger P, Rosenfeld RG, Tanaka T, Chaussain JL, Savage MO (1998) Diagnosis and treatment of growth hormone deficiency in children and adolescents: towards a consensus. Ten years after the Availability of Recombinant Human Growth Hormone Workshop held in Pisa, Italy, 27–28 March 1998. Horm Res 50:320–340

    Article  CAS  PubMed  Google Scholar 

  78. Bryant J, Cave C, Mihaylova B, Chase D, McIntyre L, Gerard K, Milne R (2002) Clinical effectiveness and cost-effectiveness of growth hormone in children: a systematic review and economic evaluation. Health Technol Assess 6:1–168

    Article  PubMed  Google Scholar 

  79. Gharib H, Cook DM, Saenger PH, Bengtsson BA, Feld S, Nippoldt TB, Rodbard HW, Seibel JA, Vance ML, Zimmermann D, Palumbo PJ, Bergman DA, Garber JR, Hamilton CR Jr, Petak SM, Rettinger HI, Service FJ, Shankar TP, Stoffer SS, Tourletot JB, American Association of Clinical Endocrinologists Growth Hormone Task Force (2003) American Association of Clinical Endocrinologists medical guidelines for clinical practice for growth hormone use in adults and children—2003 update. Endocr Pract 9:64–76

    Article  PubMed  Google Scholar 

  80. National Kidney Foundation (NKF) (2003) National Kidney Foundation Kidney Disease Outcomes Quality Initiative. Clinical practice guidelines for bone metabolism and disease in chronic kidney disease. Am J Kidney Dis 42(Suppl 3):S1–S201

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pediatrics, Division of Pediatric Nephrology, The Ohio State University COMPH, Columbus, OH, USA

    John D. Mahan

  2. The Children’s Mercy Hospitals and Clinics, Section of Pediatric Nephrology, Kansas City, MO, USA

    Bradley A. Warady

Authors
  1. John D. Mahan
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Bradley A. Warady
    View author publications

    You can also search for this author in PubMed Google Scholar

Consortia

Consensus Committee

Corresponding author

Correspondence to John D. Mahan.

Additional information

Members of the Consensus Committee that participated in this survey: Paul Fielder, PhD; Debbie S. Gipson, MD; Larry Greenbaum, MD, PhD; Marisa D. Juarez-Congelosi, BS, RD, LD; Frederick J. Kaskel, MD, PhD; Craig B. Langman, MD; Lynn D. Long, RN, MS; Dina Macdonald, RN, BSN, CNN; Deborah H. Miller, RN, MSN, CNN; Mark M. Mitsnefes, MD, MS; Valerie M. Panzarino, MD; Ron G. Rosenfeld, MD; Mouin G. Seikaly, MD; Brian Stabler, PhD; Sandra L. Watkins, MD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Mahan, J.D., Warady, B.A. & Consensus Committee. Assessment and treatment of short stature in pediatric patients with chronic kidney disease: a consensus statement. Pediatr Nephrol 21, 917–930 (2006). https://doi.org/10.1007/s00467-006-0020-y

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00467-006-0020-y

Keywords

Search

Navigation